Personal information

Activities

Employment (5)

Duke University: Durham, NC, US

2019-01-09 to present | Professor
Employment
Source: Self-asserted source
Mustafa Khasraw

The University of Sydney: Sydney, NSW, AU

2013-09-03 to present | Honorary Professor (NHMRC Clinical Trials Centre)
Employment
Source: Self-asserted source
Mustafa Khasraw

Deakin University - Geelong Campus at Waurn Ponds: Geelong, VIC, AU

2011-04 to present (Medicine)
Employment
Source: Self-asserted source
Mustafa Khasraw

Barwon Health: Geelong, VIC, AU

2011-02-04 to 2017-06-30 | Medical Oncologist (Andrew Love Cancer Centre )
Employment
Source: Self-asserted source
Mustafa Khasraw

Memorial Sloan-Kettering Cancer Center: New York, NY, US

2009 to 2011 | Clinical Fellow
Employment
Source: Self-asserted source
Mustafa Khasraw

Education and qualifications (1)

Rijksuniversiteit Groningen: Groningen, Groningen, NL

2001-04-02 | MD
Education
Source: Self-asserted source
Mustafa Khasraw

Works (50 of 100)

Items per page:
Page 1 of 2

Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas

Cancers
2023-05 | Journal article | Author
Contributors: Alexander Yuile; Joe Wei; Aditya A. Mohan; Kelly M. Hotchkiss; Mustafa Khasraw
Source: check_circle
Multidisciplinary Digital Publishing Institute

EMT Molecular Signatures of Pancreatic Neuroendocrine Neoplasms

International Journal of Molecular Sciences
2022-11 | Journal article | Author
Contributors: Abhirami Venugopal; Agnes Michalczyk; Mustafa Khasraw; Leigh Ackland
Source: check_circle
Multidisciplinary Digital Publishing Institute

PARP Inhibitors in Glioma: A Review of Therapeutic Opportunities

Cancers
2022-02 | Journal article | Author
Contributors: Hao-Wen Sim; Evanthia Galanis; Mustafa Khasraw
Source: check_circle
Multidisciplinary Digital Publishing Institute

Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy

Cells
2021-08 | Journal article | Author
Contributors: Hinda Najem; Mustafa Khasraw; Amy Heimberger
Source: check_circle
Multidisciplinary Digital Publishing Institute

Molecular and clonal evolution in recurrent metastatic gliosarcoma.

Cold Spring Harbor molecular case studies
2020-01 | Journal article
Contributors: Anderson KJ; Tan AC; Parkinson J; Back M; Kastelan M; Newey A; Brewer J; Wheeler H; Hudson AL; Amin SB et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention.

JMIR research protocols
2019-12 | Journal article
Contributors: Guccione L; Gough K; Drosdowsky A; Fisher K; Price T; Pavlakis N; Khasraw M; Wyld D; Ransom D; Kong G et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Longitudinal molecular trajectories of diffuse glioma in adults.

Nature
2019-11 | Journal article
Contributors: Barthel FP; Johnson KC; Varn FS; Moskalik AD; Tanner G; Kocakavuk E; Anderson KJ; Abiola O; Aldape K; Alfaro KD et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

The epidemiology of emergency presentations for falls from height across Western Victoria, Australia.

Australasian emergency care (Online)
2019-10 | Journal article
Contributors: Holloway-Kew KL; Baker TR; Sajjad MA; Kotowicz MA; Livingston PM; Khasraw M; Hakkennes S; Dunning TL; Brumby S; Page RS et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Mapping Cancer incidence across Western Victoria: the association with age, accessibility, and socioeconomic status among men and women.

BMC cancer
2019-09 | Journal article
Contributors: Cowdery SP; Sajjad MA; Holloway-Kew KL; Mohebbi M; Williams LJ; Kotowicz MA; Livingston PM; Khasraw M; Hakkennes S; Dunning TL et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

MYCN amplification drives an aggressive form of spinal ependymoma.

Acta neuropathologica
2019-08 | Journal article
Contributors: Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

The epidemiology of emergency presentations for falls across Western Victoria, Australia.

Australasian emergency care (Online)
2019-08 | Journal article
Contributors: Holloway-Kew KL; Baker TR; Sajjad MA; Kotowicz MA; Livingston PM; Khasraw M; Hakkennes S; Dunning TL; Brumby S; Page RS et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Traveling With Cancer: A Guide for Oncologists in the Modern World.

Journal of global oncology
2019-07 | Journal article
Contributors: Heng S; Hughes B; Hibbert M; Khasraw M; Lwin Z
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Reflecting on survivorship outcomes to aid initial decision making in patients treated for IDH-mutated anaplastic glioma.

Cancer
2019-06 | Journal article
Contributors: Back MF; Jayamanne D; Back E; Kastelan M; Khasraw M; Wong M; Brown C; Wheeler H
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Revision joint replacement surgeries of the hip and knee across geographic region and socioeconomic status in the western region of Victoria: a cross-sectional multilevel analysis of registry data.

BMC musculoskeletal disorders
2019-06 | Journal article
Contributors: Brennan-Olsen SL; Vogrin S; Graves S; Holloway-Kew KL; Page RS; Sajjad MA; Kotowicz MA; Livingston PM; Khasraw M; Hakkennes S et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Association between area-level socioeconomic status, accessibility and diabetes-related hospitalisations: a cross-sectional analysis of data from Western Victoria, Australia.

BMJ open
2019-05 | Journal article
Contributors: Sajjad MA; Holloway-Kew KL; Mohebbi M; Kotowicz MA; de Abreu LLF; Livingston PM; Khasraw M; Hakkennes S; Dunning TL; Brumby S et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
2019-04 | Journal article
Contributors: Back M; Jayamanne D; Brazier D; Newey A; Bailey D; Schembri G; Hsiao E; Khasraw M; Wong M; Kastelan M et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2019-03 | Journal article
Contributors: Chang SM; Messersmith H; Ahluwalia M; Andrews D; Brastianos PK; Gaspar LE; Gatson NTN; Jordan JT; Khasraw M; Lassman AB et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines.

Neuro-oncology
2019-03 | Journal article
Contributors: Chang SM; Messersmith H; Ahluwalia M; Andrews D; Brastianos PK; Gaspar LE; Gatson NN; Jordan JT; Khasraw M; Lassman AB et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).

Scientific reports
2019-02 | Journal article
Contributors: Ha W; Sevim-Nalkiran H; Zaman AM; Matsuda K; Khasraw M; Nowak AK; Chung L; Baxter RC; McDonald KL
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response.

PloS one
2019-02 | Journal article
Contributors: Murphy C; Muscat A; Ashley D; Mukaro V; West L; Liao Y; Chisanga D; Shi W; Collins I; Baron-Hay S et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Anti‐epidermal growth factor receptor therapy for glioblastoma in adults.

The Cochrane database of systematic reviews
2019-01 | Journal article
Contributors: Lee A; Arasaratnam M; Chan DLH; Khasraw M; Howell VM; Wheeler H; Platt J
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.

Journal of medical imaging and radiation oncology
2019-01 | Journal article
Contributors: Back M; Jayamanne DT; Brazier D; Newey A; Bailey D; Schembri GP; Hsiao E; Khasraw M; Wong M; Kastelan M et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Anti-angiogenic therapy for high-grade glioma.

The Cochrane Database of Systematic Reviews
2018-11 | Journal article
Contributors: Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM).

Neuro-oncology
2018-11 | Journal article
Contributors: Khasraw M; Weller M; Estelles DL; Kolibaba K; Lee C; Gedye C; De La Fuente M; Vicente D; Reardon D; Ojalvo L et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

EPID-13. ANTI-ANGIOGENIC THERAPY FOR HIGH-GRADE GLIOMA: A META-ANALYSIS.

Neuro-oncology
2018-11 | Journal article
Contributors: Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS.

Neuro-oncology
2018-11 | Journal article
Contributors: Khasraw M; McDonald K; Yip S; Verhaak R; Heimberger A; Hall M; Fisher L; Barnes E; Rosenthal M; Gedye C et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre.

Brain sciences
2018-10 | Journal article
Contributors: Back M; Jayamanne D; Cove N; Wheeler H; Khasraw M; Guo L; Back J; Wong M
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Profiles of brain metastases: Prioritization of therapeutic targets.

International journal of cancer
2018-10 | Journal article
Contributors: Ferguson SD; Zheng S; Xiu J; Zhou S; Khasraw M; Brastianos PK; Kesari S; Hu J; Rudnick J; Salacz ME et al.
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress.

Neuro-oncology
2018-09 | Journal article
Contributors: Khasraw M; McDonald K; Yip S; Verhaak RG; Heimberger AB; Hall M; Barnes E; Hovey E; Ellingson BM; Lwin Z
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Combination of palbociclib and radiotherapy for glioblastoma.

Cell death discovery
2017 | Journal article
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Combining PARP inhibitors with radiation therapy for the treatment of glioblastoma: Is PTEN predictive of response?

Clinical and Translational Oncology
2017 | Journal article
EID:

2-s2.0-84988569076

Contributors: Lester, A.; Rapkins, R.; Nixdorf, S.; Khasraw, M.; McDonald, K.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance

Theranostics
2017 | Journal article
Source: Self-asserted source
Mustafa Khasraw
grade
Preferred source (of 2)‎

Immune Checkpoint Inhibitors for Brain Metastases

Current Oncology Reports
2017 | Journal article
EID:

2-s2.0-85018508936

Contributors: Tan, A.C.; Heimberger, A.B.; Menzies, A.M.; Pavlakis, N.; Khasraw, M.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Immune Checkpoint Inhibitors in Gliomas

Current Oncology Reports
2017 | Journal article
EID:

2-s2.0-85015719783

Contributors: Tan, A.C.; Heimberger, A.B.; Khasraw, M.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Management of breast cancer brain metastases: A practical review

Breast
2017 | Journal article
EID:

2-s2.0-84994718553

Contributors: Phillips, C.; Jeffree, R.; Khasraw, M.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Reply to Dr Altundag from the authors of ‘Management of breast cancer brain metastases; a practical review’

Breast
2017 | Journal article
EID:

2-s2.0-85008178624

Contributors: Phillips, C.; Jeffree, R.; Khasraw, M.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy

International Journal of Radiation Oncology Biology Physics
2017 | Journal article
EID:

2-s2.0-85020379326

Contributors: Harris, G.; Jayamanne, D.; Wheeler, H.; Gzell, C.; Kastelan, M.; Schembri, G.; Brazier, D.; Cook, R.; Parkinson, J.; Khasraw, M. et al.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma

Journal of Translational Medicine
2017 | Journal article
EID:

2-s2.0-85015421724

Contributors: Jue, T.R.; Nozue, K.; Lester, A.J.; Joshi, S.; Schroder, L.B.W.; Whittaker, S.P.; Nixdorf, S.; Rapkins, R.W.; Khasraw, M.; McDonald, K.L.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.

Clinical cancer research : an official journal of the American Association for Cancer Research
2017-08 | Journal article
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

The New England journal of medicine
2017-07 | Journal article
Source: Self-asserted source
Mustafa Khasraw via Europe PubMed Central

P01.20 Treatment of recurrent glioblastoma with the cytokine inhibitor, ibudilast in combination with temozolomide

Neuro-Oncology
2017-04 | Journal article
Contributors: K. L. McDonald; W. Ha; M. Khasraw
Source: Self-asserted source
Mustafa Khasraw via Crossref Metadata Search

A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types of health care appointments

JNCCN Journal of the National Comprehensive Cancer Network
2016 | Journal article
EID:

2-s2.0-84961578446

Contributors: Wong, S.F.; Norman, R.; Dunning, T.L.; Ashley, D.M.; Khasraw, M.; Hayes, T.M.; Collins, I.; Lorgelly, P.K.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial

Journal of Neuro-Oncology
2016 | Journal article
EID:

2-s2.0-84959497239

Contributors: Khasraw, M.; Lee, A.; McCowatt, S.; Kerestes, Z.; Buyse, M.E.; Back, M.; Kichenadasse, G.; Ackland, S.; Wheeler, H.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Evolving management of low grade glioma: No consensus amongst treating clinicians

Journal of Clinical Neuroscience
2016 | Journal article
EID:

2-s2.0-84952637714

Contributors: Field, K.M.; Rosenthal, M.A.; Khasraw, M.; Sawkins, K.; Nowak, A.K.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

BMC Cancer
2016 | Journal article
EID:

2-s2.0-84971576958

Contributors: Segelov, E.; Waring, P.; Desai, J.; Wilson, K.; Gebski, V.; Thavaneswaran, S.; Elez, E.; Underhill, C.; Pavlakis, N.; Chantrill, L. et al.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Immune checkpoint blockade as a potential therapeutic target: Surveying CNS malignancies

Neuro-Oncology
2016 | Journal article
EID:

2-s2.0-84991396048

Contributors: Garber, S.T.; Hashimoto, Y.; Weathers, S.-P.; Xiu, J.; Gatalica, Z.; Verhaak, R.G.W.; Zhou, S.; Fuller, G.N.; Khasraw, M.; De Groot, J. et al.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy

Expert Review of Anticancer Therapy
2016 | Journal article
EID:

2-s2.0-84958537521

Contributors: Khasraw, M.; Ananda, S.; Michael, M.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Prioritization schema for immunotherapy clinical trials in glioblastoma

OncoImmunology
2016 | Journal article
EID:

2-s2.0-84969610644

Contributors: Hodges, T.R.; Ferguson, S.D.; Caruso, H.G.; Kohanbash, G.; Zhou, S.; Cloughesy, T.F.; Berger, M.S.; Poste, G.H.; Khasraw, M.; Ba, S. et al.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian gastro-intestinal trials group ICECREAM study

Journal of Clinical Oncology
2016 | Journal article
EID:

2-s2.0-84976351874

Contributors: Segelov, E.; Thavaneswaran, S.; Waring, P.M.; Desai, J.; Robledo, K.P.; Gebski, V.J.; Elez, E.; Nott, L.M.; Karapetis, C.S.; Lunke, S. et al.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier

Retrospective analysis of cancer survival across South-Western Victoria in Australia

Australian Journal of Rural Health
2016 | Journal article
EID:

2-s2.0-84933556328

Contributors: Wong, S.F.; Matheson, L.; Morrissy, K.; Pitson, G.; Ashley, D.M.; Khasraw, M.; Lorgelly, P.K.; Henry, M.J.
Source: Self-asserted source
Mustafa Khasraw via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (45 reviews for 10 publications/grants)

Review activity for International journal of radiation oncology, biology, physics. (1)
Review activity for Laboratory investigation. (1)
Review activity for Nature communications (2)
Review activity for Nature medicine. (3)
Review activity for Neuro-oncology advances. (2)
Review activity for Neuro-oncology. (32)
Review activity for Neurotherapeutics. (1)
Review activity for Oncogene. (1)
Review activity for Targeted oncology. (1)
Review activity for The lancet oncology. (1)